Brompheniramine
LC Conditions
Column
Chirex (S)-VAL and (R)-NEA, LC Column 250 x 4.6 mm, Ea
Brand
Chirex
Part No
00G-3014-E0
Phase Name
3014 (S)-valine and (R)-1-(alpha-naphthyl)ethylamine
Elution Type
Isocratic
Mobile Phase
A: Hexane/Dichloroethane/Ethanol-TFA (50:35:15) ethanol-TFA (10:1)
Gradient Profile
Step No.
Time(min)
%A
%B
1
0
100
0
Flow Rate
0.70 mL/min
Temperature
22°C
Detection
UV-Vis Abs.-Variable Wave.(UV) @ (22°C)
Detection Info
Order Items Used in This Application
- 1. Brompheniramine
- 2. Brompheniramine
-OEChem-06211003152D<br><br> 38 39 0 1 0 0 0 0 0999 V2000<br> 4.5981 -3.5000 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 2.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.3301 0.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 0.5000 0.0000 C 0 0 3 0 0 0 0 0 0 0 0 0<br> 3.7320 1.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 2.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 -0.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.4641 1.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 -1.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.4641 -1.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.4641 2.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 3.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.0000 2.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 -2.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.4641 -2.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.3301 2.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 -2.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.1962 1.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.1962 2.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 1.1200 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.1215 1.1077 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.5200 0.4174 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.3426 1.8923 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.9441 2.5826 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.1951 -0.6900 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.0010 -0.6900 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.9272 2.3100 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.4860 3.5000 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 4.1200 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.2460 3.5000 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1.6900 2.5369 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1.4631 1.6900 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.3100 1.4631 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.1951 -2.3100 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.0010 -2.3100 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.3301 3.1200 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.7331 0.6900 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.7331 2.3100 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1 17 1 0 0 0 0<br> 2 6 1 0 0 0 0<br> 2 12 1 0 0 0 0<br> 2 13 1 0 0 0 0<br> 3 8 1 0 0 0 0<br> 3 18 2 0 0 0 0<br> 4 5 1 0 0 0 0<br> 4 7 1 0 0 0 0<br> 4 8 1 0 0 0 0<br> 4 20 1 0 0 0 0<br> 5 6 1 0 0 0 0<br> 5 21 1 0 0 0 0<br> 5 22 1 0 0 0 0<br> 6 23 1 0 0 0 0<br> 6 24 1 0 0 0 0<br> 7 9 2 0 0 0 0<br> 7 10 1 0 0 0 0<br> 8 11 2 0 0 0 0<br> 9 14 1 0 0 0 0<br> 9 25 1 0 0 0 0<br> 10 15 2 0 0 0 0<br> 10 26 1 0 0 0 0<br> 11 16 1 0 0 0 0<br> 11 27 1 0 0 0 0<br> 12 28 1 0 0 0 0<br> 12 29 1 0 0 0 0<br> 12 30 1 0 0 0 0<br> 13 31 1 0 0 0 0<br> 13 32 1 0 0 0 0<br> 13 33 1 0 0 0 0<br> 14 17 2 0 0 0 0<br> 14 34 1 0 0 0 0<br> 15 17 1 0 0 0 0<br> 15 35 1 0 0 0 0<br> 16 19 2 0 0 0 0<br> 16 36 1 0 0 0 0<br> 18 19 1 0 0 0 0<br> 18 37 1 0 0 0 0<br> 19 38 1 0 0 0 0<br>M END
Compound Name
Brompheniramine
CID
6834
Molecular Formula
C16H19BrN2
Molecular Weight
319
No. Hydrogen Bond Acceptors
2
Similar Applications
Reversed Phase
Cold medicine compounds on Kinetex 2.6 µm EVO C18
Kinetex 2.6 µm EVO C18 100 Å, LC Column 100 x 4.6 mm, EA
23036
Reversed Phase
Pheniramine and Halogenated Derivatives on Kinetex 2.6u EVO C18 100x4.6mm
Kinetex 2.6 µm EVO C18 100 Å, LC Column 100 x 4.6 mm, EA
22972
Bromopheniramine on Lux 5µm Amylose-2 in NP
20082
Application Specific
Drug screen by MSD on a ZB-Drug1
Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea
18175
Brompheniramine on Lux 5 µm Amylose-2 250 x 4.6mm in NP
18102
Standard
Drug Screen on ZB-XLB
Zebron ZB-XLB, GC Cap. Column 30 m x 0.25 mm x 0.50 µm, Ea
16463
Drug screen on ZB-5MSi
16421
High Temperature
Drug Screen on ZB-1HT
Zebron ZB-1HT, GC Cap. Column 30 m x 0.25 mm x 0.10 µm, Ea
16227
Standard
Common Drug Screen on ZB-50
Zebron ZB-50, GC Cap. Column 30 m x 0.25 mm x 0.25 µm, Ea
16012
Standard
Common Drug Screen on ZB-35
Zebron ZB-35, GC Cap. Column 30 m x 0.25 mm x 0.25 µm, Ea
16010
Standard
Common Drug Screen on ZB-5MS
Zebron ZB-5MS, GC Cap. Column 20 m x 0.18 mm x 0.18 µm, Ea
16009
Common Drug Screen on ZB-1MS
16008